Lexicon Pharmaceuticals
LXRX
LXRX
135 hedge funds and large institutions have $1.89B invested in Lexicon Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 41 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 136 → 135 (-1)
4% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 23
13% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 47
Holders
135
Holding in Top 10
2
Calls
$16.4M
Puts
$2.23M
Top Buyers
| 1 | +$57.7M | |
| 2 | +$11.8M | |
| 3 | +$8.36M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.99M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.36M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$10.5M | |
| 3 | -$7.81M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.57M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$7.38M |